These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 30628835)

  • 1. Gastrointestinal non-motor dysfunction in Parkinson's disease model rats with 6-hydroxydopamine.
    Feng XY; Yang J; Zhang X; Zhu J
    Physiol Res; 2019 Apr; 68(2):295-303. PubMed ID: 30628835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the vagal pathway and gastric dopamine in the gastroparesis of rats after a 6-hydroxydopamine microinjection in the substantia nigra.
    Zheng LF; Song J; Fan RF; Chen CL; Ren QZ; Zhang XL; Feng XY; Zhang Y; Li LS; Zhu JX
    Acta Physiol (Oxf); 2014 Jun; 211(2):434-46. PubMed ID: 24410908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced expression of choline acetyltransferase in vagal motoneurons and gastric motor dysfunction in a 6-OHDA rat model of Parkinson's disease.
    Zheng LF; Wang ZY; Li XF; Song J; Hong F; Lian H; Wang Q; Feng XY; Tang YY; Zhang Y; Zhu JX
    Brain Res; 2011 Oct; 1420():59-67. PubMed ID: 21955729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response of colonic motility to dopaminergic stimulation is subverted in rats with nigrostriatal lesion: relevance to gastrointestinal dysfunctions in Parkinson's disease.
    Levandis G; Balestra B; Siani F; Rizzo V; Ghezzi C; Ambrosi G; Cerri S; Bonizzi A; Vicini R; Vairetti M; Ferrigno A; Pastoris O; Blandini F
    Neurogastroenterol Motil; 2015 Dec; 27(12):1783-95. PubMed ID: 26433214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pirouetting pigs: A large non-primate animal model based on unilateral 6-hydroxydopamine lesioning of the nigrostriatal pathway.
    Christensen AB; Sørensen JCH; Ettrup KS; Orlowski D; Bjarkam CR
    Brain Res Bull; 2018 May; 139():167-173. PubMed ID: 29462643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of dopaminergic markers in gastrointestinal tract of different rodent models of Parkinson's disease.
    Tian YM; Chen X; Luo DZ; Zhang XH; Xue H; Zheng LF; Yang N; Wang XM; Zhu JX
    Neuroscience; 2008 May; 153(3):634-44. PubMed ID: 18420351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron accumulation and microglia activation contribute to substantia nigra hyperechogenicity in the 6-OHDA-induced rat model of Parkinson's disease.
    Zhu Y; Wang B; Tao K; Yang H; Wang Y; Zhou T; Yang Y; Yuan L; Liu X; Duan Y
    Parkinsonism Relat Disord; 2017 Mar; 36():76-82. PubMed ID: 28108264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New ghrelin agonist, HM01 alleviates constipation and L-dopa-delayed gastric emptying in 6-hydroxydopamine rat model of Parkinson's disease.
    Karasawa H; Pietra C; Giuliano C; Garcia-Rubio S; Xu X; Yakabi S; Taché Y; Wang L
    Neurogastroenterol Motil; 2014 Dec; 26(12):1771-82. PubMed ID: 25327342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of early and delayed treatment with an mGluR5 antagonist on motor impairment, nigrostriatal damage and neuroinflammation in a rodent model of Parkinson's disease.
    Ambrosi G; Armentero MT; Levandis G; Bramanti P; Nappi G; Blandini F
    Brain Res Bull; 2010 Apr; 82(1-2):29-38. PubMed ID: 20100549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased synaptic plasticity in the medial prefrontal cortex underlies short-term memory deficits in 6-OHDA-lesioned rats.
    Matheus FC; Rial D; Real JI; Lemos C; Ben J; Guaita GO; Pita IR; Sequeira AC; Pereira FC; Walz R; Takahashi RN; Bertoglio LJ; Da Cunha C; Cunha RA; Prediger RD
    Behav Brain Res; 2016 Mar; 301():43-54. PubMed ID: 26707254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Estrogen protects the dopaminergic neurons in substantia nigra against damage induced by 6-hydroxydopamine].
    Meng JL; Ma YY; Luo HY; Kong SZ; He YW; Dong BC; Wu SH; He M
    Sheng Li Xue Bao; 2008 Jun; 60(3):369-74. PubMed ID: 18560728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered Expression of D1 and D2 Dopamine Receptors in Vagal Neurons Innervating the Gastric Muscularis Externa in a Parkinson's Disease Rat Model.
    Wang ZY; Lian H; Zhou L; Zhang YM; Cai QQ; Zheng LF; Zhu JX
    J Parkinsons Dis; 2016 May; 6(2):317-23. PubMed ID: 27164043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive impairment in motor skill learning at 12 and 20 weeks post 6-OHDA- SNc lesion in rats.
    Gambhir H; Mathur R; Behari M
    Parkinsonism Relat Disord; 2011 Jul; 17(6):476-8. PubMed ID: 21367640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Group II Metabotropic Glutamate Receptors in the Striatum in Electroacupuncture Treatment of Parkinsonian Rats.
    Jia YJ; Deng JH; Zhang WZ; Sun ZL; Yang J; Yu Y; Gong XL; Jia J; Wang XM
    CNS Neurosci Ther; 2017 Jan; 23(1):23-32. PubMed ID: 27412260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time course study of fractional anisotropy in the substantia nigra of a parkinsonian rat model induced by 6-OHDA.
    Zhang W; Zhang L; Liu L; Wang X
    Behav Brain Res; 2017 Jun; 328():130-137. PubMed ID: 28390876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the antiparkinsonism and neuroprotective effects of hydrogen sulfide in acute 6-hydroxydopamine-induced animal model of Parkinson's disease: behavioral, histological and biochemical studies.
    Sarukhani M; Haghdoost-Yazdi H; Sarbazi Golezari A; Babayan-Tazehkand A; Dargahi T; Rastgoo N
    Neurol Res; 2018 Jul; 40(7):523-531. PubMed ID: 29726751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurotoxic effects of berberine on long-term L-DOPA administration in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Shin KS; Choi HS; Zhao TT; Suh KH; Kwon IH; Choi SO; Lee MK
    Arch Pharm Res; 2013 Jun; 36(6):759-67. PubMed ID: 23539311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in the motor cortical and striatal glutamatergic system and D-serine levels in the bilateral 6-hydroxydopamine rat model for Parkinson's disease.
    El Arfani A; Albertini G; Bentea E; Demuyser T; Van Eeckhaut A; Smolders I; Massie A
    Neurochem Int; 2015 Sep; 88():88-96. PubMed ID: 26172319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of gray matter atrophy following 6-hydroxydopamine lesion of the nigrostriatal system.
    Westphal R; Sumiyoshi A; Simmons C; Mesquita M; Wood TC; Williams SC; Vernon AC; Cash D
    Neuroscience; 2016 Oct; 334():166-179. PubMed ID: 27506141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of chronic, systemic treatment with the dopamine receptor agonist R-apomorphine in partially lesioned rat model of Parkinson's disease: an electrophysiological study of substantia nigra dopamine neurons.
    Gui ZH; Liu J; Wang Y; Ali U; Wang T; Chen L
    Chin J Physiol; 2011 Apr; 54(2):96-104. PubMed ID: 21789890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.